Kura Oncology Inc expected to post a loss of 63 cents a share - Earnings Preview

Kura Oncology

06/11/2024 04:51

* Kura Oncology Inc  KURA.OQ   KURA.O  is expected to show
no
change in quarterly revenue when it reports  results on November
7 for the period ending September 30 2024
    * 
    * ​LSEG's mean analyst estimate for Kura Oncology Inc is for
a
loss of 63 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 14 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Kura
Oncology Inc
is $32.00​, above​ its last closing price of $17.52. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -0.62       -0.63      -0.59     Beat    6.2
 Mar. 31 2024  -0.54       -0.55      -0.59     Missed  -7.3
 Dec. 31 2023  -0.54       -0.55      -0.55     Met     -0.1​
 Sep. 30 2023  -0.54       -0.55      -0.50     Beat    9
 ​​Jun.        -0.55       -0.55      -0.53     Beat    3.6
 30 2023                                                
 Mar. 31 2023  -0.53       -0.54      -0.50     Beat    8.1​
 Dec. 31 2022  -0.57       -0.57      -0.49     Beat    14.3
 Sep. 30 2022  -0.55       -0.56      -0.53     Beat    5.7
 This summary was machine generated November 6 at 04:51 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)